New Orleans, LA (PRWEB) July 21, 2015
The annual meeting of The American Association of Nurse Practitioners (AANP), the largest national conference for Nurse Practitioners, took place from Tuesday, June 9th to Sunday, June 14th in New Orleans, LA, marking the 50th anniversary of the first Nurse Practitioner program. Among the exhibitions at this year’s conference was Relizen, a new non-hormonal, non-phytoestrogenic therapy for the relief of hot flashes associated with menopause made from natural flower pollen. Recently launched in the U.S., Relizen has been used by women and physicians in Europe for more than 15 years and has clinical efficacy established in multiple trials which have been published in peer reviewed journals, including Climacteric.
Diane Pace, PhD, APRN, NCMP, FAANP, presented her perspective on “The Menopausal Woman: Reviewing the Evidence and Developing a Collaborative Plan for Primary Care.” In addition, Dr. Pace hosted the Relizen dinner reception on Friday June 12th in New Orleans. “Dr. Pace has a long-standing collaborative relationship with important organizations such as, the American Association of Nurse Practitioners (AANP), the North American Menopause Society (NAMS), and the Association of Professors of Gynecology and Obstetrics (APGO), working to define and present better treatment options and other issues associated with menopause. JDS is thrilled to have Dr. Pace support the science and treatment benefits associated with Relizen, for the relief of hot flashes associated with menopause,” stated Michael Quinn, Vice President of Sales at JDS Therapeutics.
About Dr. Diane Pace
Dr. Diane Pace is a Clinical Professor at the University of Memphis Loewenberg School of Nursing, a family nurse practitioner providing primary care and menopausal health care at the Methodist Teaching Practice, and is currently teaching in the University of Memphis School of Nursing clinical program in the Family Nurse Practitioner track. Recipient of the 2014 NPWH Inspirations in Women’s Health Award, Dr. Pace was the first nurse practitioner to serve as president of the North American Menopause Society (NAMS) and is a NAMS Certified Menopause Practitioner. Dr. Pace has published on menopause and is a contributor to the NAMS Menopause Practice: A Clinician’s Guide textbooks. She served on the Menopause Curriculum Task Force to develop a curriculum for residents and other clinicians by NAMS and the Association of Professors of Gynecology and Obstetrics (APGO), and serves on the NAMS Scientific Committee, and as a reviewer for the journal of Menopause. She is a Fellow in the American Association of Nurse Practitioners, presents at their national conferences, and was awarded the 2013 AANP Nurse Practitioner State Excellence Award.
About the American Association of Nurse Practitioners
The AANP represents the interests of the approximately 205,000 NPs around the United States, advocating for the active role of NPs as providers of high-quality, cost-effective, comprehensive, patient-centered care. This year, the AANP conference had up to 38 contact hours of continuing education (CE) offerings, updates on state and federal policy, networking hours, an exhibit hall filled with the latest goods and services for NPs and students, and of course, influential speakers who shared their unique perspectives on the role of the nurse practitioner in the dynamic health care environment. Additional information on AANP is available at http://www.aanp.org.
About JDS Therapeutics
JDS Therapeutics markets proprietary, high-quality healthcare products to physicians and patients. JDS is focused on providing patients with scientifically backed, natural approaches to meeting their healthcare needs, and owns more than 100 issued or pending patents worldwide involving clinically active natural compounds. JDS brought Relizen to the U.S. in 2014 as a non-hormonal, non-phytoestrogen therapy made from a blend of natural Swedish flower pollen for the relief of hot flashes associated with menopause.
To find out more about Relizen, visit http://www.relizen.com/HCP or contact firstname.lastname@example.org
Relizen® is a registered trademark of JDS Therapeutics, LLC.